Activation of intracellular enzyme systems under the influence of pathogenetic factors of oncogenesis in patients with type 2 diabetes mellitus
Journal Title: Міжнародний ендокринологічний журнал - Year 2019, Vol 15, Issue 3
Abstract
Background. It is proved that patients with diabetes mellitus (DM) have an increased risk of cancer. The main factors of oncogenesis in DM are obesity, cytokine imbalance, hyperinsulinemia (HI), hyperglycemia. These disorders cause dysfunction of the intracellular regulatory signaling pathways, the main of which is PI3K/Akt/mTOR. The purpose of the work was to study the role of phosphorylated Akt-protein kinase (phospho-Akt) in the oncogenesis processes in patients with type 2 DM. Materials and methods. Seventy-five people were examined. Patients were divided into groups: І — healthy, ІІ — persons with DM type 2, ІІІ — patients with cancer, IV — patients with cancer and DM type 2. Patients with breast, endometrial, pancreatic and intestinal cancer were included in the study. The levels of insulin, insulin-like growth factor 1 (IGF-1) and phospho-Akt were determined. Results. Patients of groups II and IV had a decompensated DM with HbA1c level > 8.0 %. Reliable HI was found in patients with DM in groups II and IV (p < 0.05), IGF-1 level was increased in all study groups (p < 0.05). Levels of phospho-Akt in patients from groups II and III were elevated (p < 0.05) and in group IV — reduced (p < 0.05). In the third group, HI in patients with breast, endometrial and intestinal cancer (p < 0.05) was detected, as well as elevation of IGF-1 regardless of localization (p < 0.05). In group IV, increased content of insulin and IGF-1 were detected in patients with breast and endometrial cancer (p < 0.05). In women from group III with breast and endometrial cancer, the level of IGF-1 was higher than that of group IV (p < 0.05). In patients treated with metformin monotherapy, phospho-Akt level was significantly lower (p < 0.05). There was a direct correlation between phospho-Akt and IGF-1 in patients of group II (r = 0.50; p < 0.05) and between phospho-Akt and insulin in group III (r = 0.45; p < 0.05). Conclusions. HI and IGF-1 are common pathogenetic factors of type 2 DM and cancer. The elevated level of phospho-Akt can serve as a laboratory indicator of cancer risk in healthy individuals. The combination of type 2 DM and cancer causes a decrease in phospho-Akt due to the competitive interaction of intracellular signaling pathways. Metformin therapy helps to reduce phospho-Akt level and can be considered as one of the ways to prevent cancer.
Authors and Affiliations
T. S. Vatseba
Keywords
Related Articles
- EP ID EP605828
- DOI 10.22141/2224-0721.15.3.2019.172107
- Views 50
- Downloads 0
Indicators of transferrin and ferritin in overweigh and obesity children
Background. Today, obesity is seen as a chronic systemic inflammation of low activity. At present, the information about the biological and clinical significance of metal proteins in the inflammatory process is being acc...
Pathogenetic significance of proinflammatory cytokines and dyslipidemia in the development of cardiovascular complications in patients with hypothyroidism
Background. The manifestation of violations in the morphofunctional state of the cardiovascular system is on one of the first places in the symptomatology of hypothyroidism, which is associated with various direct and in...
Status of bone mineral density in male patients with primary hypothyroidism
Background. The issue of hypothyroidism effect on bone tissue is underinvestigated, due to the small number of studies. In addition, it’s not easy to determine the effect of reduced thyroid function on bone strength due...
The influence of peripheral diabetic sensorimotor neuropathy on the state of cognitive function in elderly patients with type 2 diabetes mellitus
Background. Dementia is a disease that affects all aspects of the patient’s life. But identifying cognitive impairment in the early stages is a difficult task. Therefore, it is necessary to search for a possible relation...
Economic Efficiency of Neonatal Screening for Congenital Adrenal Hyperplasia in Ukraine
In 2012, neonatal screening (NS) for congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency has been introduced in Ukraine. For a year, as part of the screening we have examined 493,580 newborns. In total,...